Pharmacogenomic information in drug labels: European Medicines Agency perspective

Cancer Drug Development and the Evolving Regulatory Framework for Companion Diagnostics in the European Union

(2014) F. Pignatti et al.   CLINICAL CANCER RESEARCH

Policies to aid the adoption of personalized medicine

(2014) Charity Nofziger et al.   NATURE REVIEWS DRUG DISCOVERY

Genetics of platelet inhibitor treatment

(2013) Dietmar Trenk et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Response Variability to P2Y12 Receptor Inhibitors

(2013) Jolanta M. Siller-Matula et al.   JACC-Cardiovascular Interventions

Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective

(2013) Marc Maliepaard et al.   NATURE REVIEWS DRUG DISCOVERY

An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancer

(2013) Melanie Poulin-Costello et al.   Targeted Oncology

Mutant KRAS Codon 12 and 13 Alleles in Patients With Metastatic Colorectal Cancer: Assessment As Prognostic and Predictive Biomarkers of Response to Panitumumab

(2012) Marc Peeters et al.   JOURNAL OF CLINICAL ONCOLOGY

Ivacaftor

(2012) Pamela B. Davis et al.   NATURE REVIEWS DRUG DISCOVERY

Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

(2011) Matthew J. Price   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation

(2011) Bonnie W. Ramsey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice

(2010) Felix W Frueh   PHARMACOGENOMICS

CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans

(2010) A LLerena et al.   PHARMACOGENOMICS JOURNAL

Ethical and Social Issues in Pharmacogenomics Testing

(2009) S. Vijverberg et al.   CURRENT PHARMACEUTICAL DESIGN

Cystic fibrosis

(2009) Brian P O'Sullivan et al.   LANCET

Pathology practice and pharmacogenomics

(2009) Ronald JA Trent   PHARMACOGENOMICS

Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

(2009) F. Van Goor et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HLA-B*5701 Screening for Hypersensitivity to Abacavir

(2008) Simon Mallal et al.   NEW ENGLAND JOURNAL OF MEDICINE

PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events

(2007) Sara Hughes et al.   PHARMACEUTICAL STATISTICS